Banggulan, Roy .
HRN: 16-79-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/07/2024
06/08/2024
IVT
500 MG
1 Hr PTOR
Urolithiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes